Atorvastatin Calcium
Product Images NDC 70934-482

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 70934-482). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Denton Pharma, Inc. Dba Northwind Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (70934 482 96 Master Bottle Label Approval Rev A 04 20)

Atorvastatin Calcium Tablets USP 10mg label for 180 tablets, distributed by Denton Pharma, Inc. DBA Northwind Pharmaceuticals. The label includes the NDC 70934-482-96, storage instructions at 20° to 25°C, dosage directions to see the package insert, and warnings to keep out of reach of children and store in original container. The label also lists inactive ingredients and manufacturing information, including lot and expiration date placeholders.*

FDA Label Image

Atorvastatin-fig-1 (Atorvastatin Fig 1)

A line graph comparing the cumulative incidence percentage over years between Atorvastatin and placebo groups. The graph shows lower cumulative incidence for Atorvastatin compared to placebo over approximately 3.5 years, with a hazard ratio (HR) and p-value noted on the chart.*

FDA Label Image

Atorvastatin-fig-2 (Atorvastatin Fig 2)

A line graph comparing the cumulative hazard percentage over up to five years of follow-up between Atorvastatin and placebo groups, showing lower hazard rates for Atorvastatin. The x-axis represents time in years to the first primary endpoint, and the y-axis shows cumulative hazard percentage. A hazard ratio (HR) of 0.63 with confidence interval 0.48 to 0.83 and p-value 0.001 is noted.*

FDA Label Image

Atorvastatin-fig-3 (Atorvastatin Fig 3)

A line graph showing the percentage of subjects experiencing an event over time to the first major cardiovascular endpoint in years. Two doses of Atorvastatin, 10 mg (dashed line) and 80 mg (solid line), are compared over a 5-year period. The graph includes a hazard ratio (HR) of 0.78 with confidence interval (0.69-0.89) and a P value of 0.0002, indicating statistical data related to event occurrence rates by dose.*

FDA Label Image

Atorvastatin-st (Atorvastatin St)

Chemical structure of Atorvastatin Calcium, showing the detailed molecular arrangement including phenyl rings, fluorophenyl group, hydroxy groups, and calcium ions with water of hydration as indicated in the formula.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.